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Saudi Journal of Ophthalmology (2012) 26, 349–356Oculoplastic Imaging UpdateMeibography: A review of techniques and technologiesRyan J. Wise, BS, BA; Rachel K. Sobel, MD; Richard C. Allen, MD, PhD ⇑AbstractMeibomian glands play a significant role in tear production by contributing lipids to the superficial tear film.1 Dysfunction of the
meibomian glands destabilizes tears resulting in evaporative dry eye.2,3 Historically, the meibomian glands were assessed in an
ex vivo fashion through histologic studies. However, innovations in ocular imaging have advanced significantly in recent decades
to include meibography. Meibography is an imaging study developed 35 years ago exclusively for the purpose of observing the
morphology of meibomian glands in vivo.4,5 In this review of meibography, we briefly describe the etiology of meibomian gland
dysfunction and then discuss various meibography techniques, technologies, and methods of image analysis. We close with a
review of the literature, crediting various studies for the significant contributions made toward our current understanding of
the meibomian glands.
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Description of the meibomian glands
The posterior lamella of the eyelid hosts a fleet of meibo-
mian glands situated between the palpebral conjunctiva and
tarsal plate. A normal meibomian gland is approximately lin-
ear and 3–4 mm in length, traversing the posterior eyelid per-
pendicularly from the lid margin to the opposite edge of the
tarsus.5 Closer inspection of a meibomian gland demon-
strates a tubulo-acinar architecture with saccular arrange-
ments of acini and a ductal system that communicates with
orifices near the mucocutaneous junction of the eyelid.6 Glan-
dular acini contain clusters of modified sebaceous cells called
meibocytes.
The functional unit of a meibomian gland is the meibocyte
which synthesizes and secretes lipids (meibum) into the pre-
corneal tear film. Meibum permeates the tear surface wherePeer review under responsibility
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ration and thus desiccation of the ocular surface; it acts as a
physical and hydrophobic barrier to the inward movement
of environmental and organic agents; and it lubricates the
ocular surface to prevent irritation while promoting a clear
ocular image. Consequently, tear physiology is dependent
upon the proper functioning of the meibomian glands.7–9
A stable tear film is essential to a healthy ocular surface.
Tears are composed of three distinct layers: the superficial
lipid layer prevents tear evaporation and is produced by
the meibomian glands in the eyelid; the intermediate aque-
ous layer hydrates the ocular surface and is produced by
the lacrimal (and accessory) gland in the superolateral orbit;
and the deep mucinous layer promotes adhesion of tears to
the ocular surface and is produced by goblet cells embedded
in the conjunctiva.1–4 Eyelid blink disburses tears along the
ocular surface that ultimately drain through the nasolacrimal
system.10,11Production and hosting by Elsevier
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The International Workshop on Meibomian Gland Dys-
function formally defined it as a chronic, diffuse abnormality
of the meibomian glands, commonly characterized by termi-
nal duct obstruction and/or qualitative/quantitative changes
in the glandular secretion.12 It may result in alteration of
the tear film, symptoms of eye irritation, clinically apparent
inflammation, and ocular surface disease.12 An optimum level
of meibum expression is required for tear stability which al-
lows for the division of MGD into two types:12–14
1. Low delivery or obstructive-type MGD: Absence or
hyposecretion of meibum results in a lipid-deficient tear
film and evaporative dry eye. Histopathologic studies of
obstructive-type MGD demonstrate squamous metaplasia
and keratinized plugs at gland orifices, inspissation of lip-
ids and cell debris within dilated ducts, gland hypertrophy,
lysis of meibocyte cell junctions, and gland atrophy.15–20
2. High delivery or seborrheic-type MGD: Hypersecretion of
meibum into the tear film incites an inflammatory reaction
at the ocular surface resulting in symptoms of eye irrita-
tion.21,22 This form of MGD is less common and studies
are limited; however, Mathers et al.17 and Arita et al.21
showed that changes in meibomian gland morphology
are not characteristic of seborrheic-type MGD.
The epidemiology of meibomian gland dysfunction
MGD is purported to be the most common cause of evap-
orative dry eye syndrome and is frequently encountered in
ophthalmic practices.3,23–26 The prevalence of MGD is esti-
mated to range from 0.39% to 69.3% in population- and clin-
ical-based studies.27–38 Such a wide variation in the
prevalence of MGD is likely due to lack of a common defini-
tion, different diagnostic methods, and normal variation in
the prevalence of MGD with age and ethnicity.25 A compari-
son of studies suggests that MGD is most prevalent in Asian
populations (46.2–69.3%) and least prevalent in Caucasian
populations (3.5–19.9%).28–32,38 To our knowledge, there
have been no studies reporting the prevalence of MGD by
age group.Methods for evaluating the meibomian glands
The multifactorial nature of dry eye syndrome necessitates
several tests in diagnosing the underlying cause(s). Dry eye is
classically divided into aqueous deficient-type and evapora-
tive-type but they frequently co-occur.3 Investigation of the
meibomian glands is warranted when clinical presentation
and/or workup suggests evaporative dry eye which is most
commonly caused by MGD.3,12,25,39 Numerous techniques
exist for directly and indirectly assessing the structure and
function of meibomian glands. Here, we briefly discuss com-
monly used techniques in both research and clinical scenarios
for evaluating the meibomian glands with an emphasis on
meibography.
Measurements of tear production and evaporation rate
The Schirmer test was first described in 1903 and is an inva-
sive method for measuring tear production.40 By measuringthe rate of tear production, the Schirmer test can indirectly
measure the function of meibomian glands. The Schirmer test
differentiates MGD from aqueous-deficient dry eye because
obstructive-type MGD results in activation of reflex tearing
secondary to ocular irritation whereas aqueous-deficient dry
eye features a reduced capacity for any reflex tearing.17,41,42
The Schirmer test should be interpreted with caution because
there are many causes of abnormal reflex tearing aside from
MGD. As a result, the Schirmer test cannot diagnose MGD.
The tear film breakup time (TBUT) was first described in
1969 by Norn and is a noninvasive method for assessing tear
stability.43,44 TBUT represents the time elapsed from the last
complete eyelid blink until appearance of the first dry spot on
the cornea. By measuring tear film stability, the TBUT can
indirectly assess the function of meibomian glands. MGD
leads to a lipid-deficient tear film that is unstable and rapidly
evaporates.45 Studies have shown that MGD leads to de-
creased TBUT; however, several causes of aqueous-deficient
and evaporative dry eye lead to decreased TBUT and it is
therefore not diagnostic of MGD.17,46–50
Biomicroscopic examination of the eyelid and digital
pressure meibum expression
Slit-lamp biomicroscopic examination of the eyelid is a
common method for assessing the meibomian glands. This
is a non-invasive examination of the eyelid for evidence of
irregular lid margins as evidenced by hyperemia, telangiecta-
sias, vascular engorgement, meibum orifice plugging, and
provocation of meibum expression through application of
digital pressure to the eyelid.51–53 These changes in eyelid
appearance and meibum expression have been shown to cor-
relate with dysfunction of the meibomian glands.54 While this
method is frequently used in the clinical setting as part of the
standard slit-lamp examination of the eyelid, it is limited as an
indirect measure of meibomian gland structure and function.
Vital stains of the ocular surface
Topical dyes reveal certain features of the ocular surface in
a relatively non-invasive, rapid, and economical manner.
Commonly used topical dyes include fluorescein, rose ben-
gal, and lissamine green. Fluorescein is a mildly invasive stain
that marks the tear film and defects in the corneal and con-
junctival epithelium.55 The tear film staining properties of flu-
oroscein also make it useful in determining the TBUT. Rose
bengal and lissamine green are conjunctival stains, but rose
bengal is considerably more invasive than lissamine green
due to its greater toxicity to the ocular surface.56,57 Topical
stains are useful for their ability to detect tear and ocular sur-
face abnormalities associated with MGD; however, there is
currently no stain for meibomian glands that can be used
in vivo.
Lipid layer interferometry
Lipid layer interferometry is a technique predominantly
utilized in research that measures tear stability by imaging
the surface contour of the tear film and analyzing the depth
or ‘‘thickness’’ of the lipid layer.58,59 On interferometry, an
appropriately thick lipid layer spans the tear surface in a
continuous manner whereas a thin lipid layer degenerates
Figure 1. Contact IR meibography. Lower eyelid probe (A) is T-shaped
on end. Upper eyelid probe (B) is linear. IR camera (C) films the everted
and transilluminated eyelid.
Figure 2. Contact IR meibography of a normal upper eyelid (A) and
normal lower eyelid (B).
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film.58,59 Previous studies have found interferometry to be
useful in diagnosing the presence and severity of dry eye,
but not at further defining the cause of dry eye such as
MGD.60,61
Tear osmolarity
Tear osmolarity depends on multiple factors including the
function of meibomian glands. Studies have shown that mei-
bum maintains tear osmolarity by preventing evaporation of
the aqueous layer.17,62 Loss of meibum expression in patients
with obstructive MGD leads to increased evaporation of
water resulting in increased tear osmolarity.17,63 Hyperosmo-
lar tears are directly irritative to the ocular surface which pro-
vides one explanation for the irritative symptoms of MGD.3,64
Technical difficulty and sample analysis are the two major
drawbacks of the tear osmolarity test. Significant care must
be taken to minimize reflex tearing during sample collection
which could alter tear osmolarity. Furthermore, tear osmolar-
ity cannot be determined clinically, but requires laboratory
analysis. Determination of tear osmolarity is limited as a test
for MGD because hyperosmolar tears are a hallmark charac-
teristic of virtually any cause of dry eye syndrome.3,64
Meibometry
Meibometry is a technique developed to measure basal
meibum levels at the eyelid margin.65–67 Essentially, a sample
of meibum at the lid margin is transferred to specialized tape
whose transparency is altered by exposure to meibum. The
degree of change in tape transparency is analyzed photomet-
rically for the purpose of quantifying the amount of basal
meibum levels at the lid margin. Studies have shown basal
meibum levels to be altered in MGD.65 Unfortunately, MGD
can be focal or diffuse, rendering meibometric analysis vul-
nerable to inconsistent measurements within a given eyelid
depending on the site of meibum collection along the lid
margin.65
Meibography
Meibography is a specialized imaging study developed
exclusively for the purpose of directly visualizing the mor-
phology of meibomian glands in vivo (Fig. 1).4,5,18,48,63 There
are several advantages to using meibography when evaluat-
ing patients with dry eye. While the methods previously dis-
cussed are capable of measuring some parameter of
meibomian gland function, they are incapable of directly
evaluating meibomian gland structure. Methods available
for directly observing the architecture of meibomian glands
are meibography and posterior eyelid biopsy. Biopsy of the
posterior eyelid demonstrates the microscopic structure of
meibomian glands, but it is an invasive ex vivo study and
many patients are reluctant to consent to such a proce-
dure.16,68 By comparison, meibography is a non-invasive
in vivo study that permits gross and microscopic examination
of the structure of meibomian glands.15–20,68 An experienced
meibographer can complete the study in minutes with mini-
mal discomfort to the patient.69 Meibographical images are
scrutinized using any of several previously described tech-
niques for quantitating gland architecture.70–72 Many studieshave verified the utility of meibography in the diagnosis and
evaluation of MGD (Fig. 2).4,5,14,17,18,48,49,63,70,73–80 We now
turn to a more complete discussion of meibography.
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A brief history of meibography
Meibography was first described in 1977 by Tapie who
used UV Woods light to fluoresce meibomian ducts on biomi-
croscopy and infrared light to illuminate the meibomian
glands on IR photography.4 In 1982, Jester et al. improved
upon Tapie’s IR photography while documenting MGD in
rabbits.5 In 1991, Mathers et al. was the first to refer to IR
photography of meibomian glands as ‘‘meibography’’ in a
study demonstrating several changes in the meibomian
glands of patients with chronic blepharitis.17 In 1994, Mathers
et al. introduced video IR meibography which represented a
major advancement in the field by reducing dependence on
the comparatively cumbersome and inefficient technique of
photographic meibography.75 Since its inception 35 years
ago, the evolution of meibography has recently accelerated
with improvements to IR meibography as well as the advent
of non-IR technologies including laser confocal meibography
and, most recently, OCT meibography.81 A description of
various meibographical techniques, technologies, and scor-
ing systems is provided in the sections to follow.Techniques in meibography
There are two meibography techniques: contact and
non-contact. Contact meibography is the traditional tech-
nique developed in the late 1970’s, involving direct appli-
cation of a light probe to the skin for eversion and
transillumination of the eyelid followed by imaging with a
specialized camera (Fig. 1).4,5,75 Contact meibography sys-
tems have enjoyed great success over the years, but there
are disadvantages. First, operator expertise is required to
properly use the equipment and attain good images. Sec-
ond, eyelids have unique physical characteristics that are
not always amenable to manipulation with the light probe.
Partial lid eversion is a common and time-consuming prob-
lem that requires several images to be taken and merged
to form a composite panoramic image of the eyelid. Third,
patients may complain of discomfort due to heat, pressure,
brightness, and sharpness of the probe.76 To address these
limitations, a newly designed ‘‘oblique T-shaped probe’’
was introduced in 2007 and claimed to improve lid manip-
ulation and image quality while reducing patient discom-
fort.76 Although advancements in contact meibography
such as the oblique T-shaped probe are well-intentioned,
they have largely been overshadowed by the introduction
of non-contact meibography.
Introduced in 2008 by Arita et al., non-contact meibogra-
phy is the latest meibographic technique.82 It uses a slit-lamp
biomicroscope with IR filter and an IR charge-coupled device
video camera to image a digitally everted eyelid. A light
probe is unnecessary in non-contact meibography and distin-
guishes it from the contact technique. By eliminating the
need for a light probe, non-contact meibography addresses
the challenges of lid manipulation and patient discomfort
commonly encountered in contact meibography. Conse-
quently, non-contact meibography claims to be faster, more
patient friendly, and easier to use than contact techniques.82
Another advantage of non-contact meibography is its ability
to view a greater surface area of the everted eyelid, requiringfewer images and less time to merge images to create a pan-
oramic view of the lid for evaluation.82
Perhaps the most convenient advancement in meibogra-
phy techniques was described in 2012 by Arita et al. who
introduced the mobile pen-shaped meibography system.83
The mobile pen-shaped meibography system is a subset of
non-contact meibography that uses an infrared LED fixed
to a handheld pen-shaped camera capable of capturing vi-
deo or photographs of the meibomian glands which are com-
parable in quality to previous meibography systems.83 Thus,
the mobile pen-shaped meibography system effectively elim-
inates the need for a slit-lamp biomicroscope typically used in
non-contact meibography. A simple, fast, and portable meib-
ography device has the potential to transform meibography
from an academic center study to a test used in common clin-
ical practice.Meibographic technologies
Infrared meibography
Although it was the first technology utilized, infrared
meibography remains the mainstay of most meibomian gland
imaging studies due to its historical familiarity and reliability
in producing high-quality gross images of the meibomian
glands (Figs. 1 and 2).4,5,75,82,83 Infrared meibography is the
technology most commonly utilized in contact and non-con-
tact techniques which were described above and, therefore,
would be redundant to discuss further. Until recently, how-
ever, infrared meibography was the only technology avail-
able, but novel technologies with the capacity to resolve
microscopic features of meibomian glands have recently
been proposed.Laser confocal meibography
Laser confocal microscopy is an imaging modality utilized
in many areas of medicine, but has recently found favor in the
field of ophthalmology for its ability to evaluate various ocu-
lar structures and evaluate ocular surface disease and ante-
rior segment disorders.84 In 2005, Kobayashi et al. was the
first to demonstrate the palpebral conjunctiva and subcon-
junctival meibomian glands using in vivo laser confocal meib-
ography (CM).85 The major advantage of CM over IR
meibography is its ability to resolve and characterize the
microenvironment and microscopic structures of the meibo-
mian glands.45,49,85 However, CM is more invasive than IR
meibography, involving alignment of the lens directly against
the posterior aspect of the everted eyelid which requires a
topical anesthetic.
Matsumoto et al. studied patients with MGD using CM
and described two new meibomian gland parameters: glan-
dular acinar unit diameter and acinar unit density.45 This
study showed that patients with MGD had an increased aci-
nar unit diameter and decreased acinar unit density, reflect-
ing inspissation of lipids and gland dropout, respectively. A
subsequent study by Matsumoto et al. used CM to follow pa-
tients with obstructive-type MGD and described two more
meibomian gland parameters: periglandular inflammatory
cell infiltrates and periglandular fibrosis.49 This study demon-
strated that patients with MGD have periglandular fibrosis as
well as increased periglandular inflammatory infiltrates that
respond favorably to topical anti-inflammatory agents. Find-
ings of periglandular inflammatory infiltrates and fibrosis
Figure 3. Contact IR meibography of meibomian gland dysfunction
involving the upper eyelid (A) and lower eyelid (B).
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versus-host disease involving the eyelid.86 The ability to
assess glandular acinar unit density, acinar unit diameter,
periglandular inflammatory infiltrates and fibrosis was shown
to have good sensitivity and specificity in diagnosing obstruc-
tive-type MGD.87 Therefore, as an in vivo technique, CM is
noteworthy for its ability to measure microscopic parameters
of the meibomian glands that were once only measurable in
an ex vivo fashion through eyelid biopsy. As such, CM repre-
sents a significant advancement in the field of meibography.
Optical coherence tomographic meibography
Representing the most recent type of meibography, opti-
cal coherence tomography was first described in 2010 by
Bizheva et al.81 OCT meibography (OCTM) is a non-invasive
method capable of obtaining 2-D and 3-D tomograms of
the meibomian glands in vivo. The distinguishing feature of
OCTM from other forms of meibography is the capability
to quantify meibomian gland morphology volumetrically. Vol-
umetric measurements of the meibomian glands were previ-
ously made possible only through ex vivo histologic studies.81
Theoretically, prospective studies using OCTM could docu-
ment the volumetric changes in the meibomian glands
thought to occur with progression of MGD, including early
gland hypertrophy and late gland atrophy.15,17,18 While
OCTM adds a new dimension to meibographic analysis, the
application of such a technology is in its infancy and its true
usefulness to the field of meibography is yet to be
defined.81,88
Meibographic image analysis
Remarkable images of the meibomian glands are gener-
ated using meibography. On IR meibography, normal meibo-
mian glands are hypoilluminescent grape-like clusters while
ducts and underlying tarsus are hyperilluminescent (Fig. 2).5
Abnormal meibomian glands show features consistent with
histopathologic studies in which ducts appear dilated and
glands become enlarged, tortuous, and eventually dropout
(Fig. 3). Detailed evaluation of meibographic images is re-
quired to quantitatively assess and compare eyelids. Grading
meibomian gland structure can be used to document the
presence, progression, and treatment response in
MGD.5,17,49 To date, meibomian gland grading is a largely
informal and poorly defined process making comparison be-
tween studies difficult. The meiboscore and meibograde sys-
tems represent methodical approaches to quantifying
meibomian gland morphology on IR meibography. Brief
descriptions of these methods are provided below.
The meiboscore method
Officially termed the ‘‘meiboscore’’ in 2008 by Arita et al.,
this method represents a variant of older grading schemes
that examine meibographs for evidence of gland drop-
out.17,54,63,70,82,89 First, meibographs are inspected for the
presence of partial or absent meibomian glands and assigned
a numerical score proportional to the area of involved eyelid.
Evaluation: (0): lid has no partial or missing glands; (1): in-
volve lid area is <33%; (2): involved lid area is 33–66%; (3): in-
volved lid area is >66%. Second, meiboscores for the upper
and lower eyelids are summed by side to derive a total
meiboscore from 0 through 6 per eye. Scores are used tocompare eyes for differences in meibomian gland morphol-
ogy which can support a diagnosis of MGD.
Interestingly, Arita et al. showed that meiboscores corre-
late with lid margin abnormality scores, effectively verifying
the meiboscore as a valid measure of meibomian gland struc-
ture.69 Further, the same study showed that meiboscores cor-
relate with meibum scores, supporting the meiboscores’
ability to infer meibomian gland function.69 The meiboscore
method is appealing because it involves a single scoring cat-
egory which streamlines image analysis and data quantifica-
tion. The simplicity of the meiboscore, however, also
represents its greatest limitation because it fails to account
for features of meibomian gland architecture that may pre-
cede gland dropout.82The meibograde method
First described in 2012 by Call et al., the meibograde
method represents the latest and most comprehensive scor-
ing system available for evaluating meibomian gland mor-
phology.72 Essentially, the meibograde comprises three
distinct categories based on previously described histopath-
ologic changes in the meibomian glands: gland distortion,
gland shortening, and gland dropout.15,17–20 It conserves
the meiboscore point system, assigning a score of 0 through
3 to each of the three categories and then sums the catego-
ries to obtain a meibograde from 0 through 9 per eyelid. Eye-
lid meiboscores can be compared for differences in
meibomian gland morphology which may be used to diag-
nose MGD.
Limitations of the meiboscore as an incomplete scoring
system prompted the development of the meibograde meth-
od. In theory, the meibograde should be able to detect minor
changes in the meibomian glands leading up to and including
dropout. However, determining the meibograde is more
laborious than previously described scoring systems, but
the added attention to detail may provide the information
necessary to identify subtle pathologic changes in the meibo-
mian glands before becoming irreversible.Review of the literature
The contribution of meibography to our understanding of
meibomian glands cannot be overstated. Studies commonly
354 R.J. Wise et al.employ meibography as part of a battery of tests to identify
changes in meibomian glands associated with certain vari-
ables. In doing so, meibography studies attempt to identify
risk factors for MGD. Here, we review some of the findings
of these studies.
Meibum synthesis is thought to be under neuroendocrine
control. Histologic studies previously identified retinoic acid,
androgen, estrogen, and progestin receptors on meibo-
cytes.24 Meibography has been used in some studies to show
that fluctuations in hormone levels could underlie the associ-
ation between MGD and age,54,82 Accutane therapy,63
androgen deficiency90–92 and hormone replacement ther-
apy.93 Furthermore, the presence of acetylcholine receptors
on meibocytes suggests a role in the neural regulation of
meibum synthesis.94–96 However, we were unable to identify
any meibography studies attempting to find an association
between cholinergic activity and changes in meibomian
gland morphology.
Eyelid muscle contraction compresses the meibomian
glands and propels meibum into the tear film.24 In the seven-
teenth century, Jean Riolan first described a set of muscle fi-
bers encircling the meibomian glands collectively known as
the muscle of Riolan.97 In 2002, Lipham et al. subsequently
showed through histologic analysis of the muscle of Riolan
that it was a component of the orbicularis muscle, relating
eyelid blink to meibum expression.98 It follows that orbicula-
ris weakness due to a number of causes (e.g. Bell’s palsy,
myotonic dystrophy, status post botulinum toxin injection)
could lead to stagnation of meibum resulting in obstruc-
tive-type MGD. Indeed, this theory was recently supported
in the literature by Call et al.72 and Shah et al.50 using IR
meibography to demonstrate an association between MGD
and both the duration and severity of orbicularis weakness
secondary to seventh nerve palsy.
In summary, the risk factors for MGD are numerous and
meibomian gland images have helped elucidate many of
them. These include age, gender, hormonal imbalance (e.g.
androgen deficiency, menopause), contact lens wear, medi-
cations (e.g. Accutane, anti-glaucoma drops, hormone
replacement therapy), eyelid anatomy, eyelid surgery, eyelid
tattooing, eye trauma, ocular radiation, orbicularis weakness
(e.g. CN VII palsy, status post botulinum toxin injection),
allergic conjunctivitis, trachoma, Sjogren’s Syndrome, Ste-
vens Johnson syndrome, atopic dermatitis, seborrheic
dermatitis, acne rosacea, chronic blepharitis, and graft-
versus-host disease.13,17,50–52,54,63,68,72,77,78,82,86,89,92,93,99–113
Clearly, a myriad of factors deserve attention when treating
MGD, which may represent a final common pathway to evap-
orative dry eye syndrome.
Conclusion
Our understanding of the meibomian glands and their
relationship to dry eye syndrome has progressed in parallel
with advances in meibography. The future of meibography
is bright. IR meibography is currently the technology of
choice for studying the morphology of meibomian glands.
The development of portable non-contact IR meibography
has the potential to popularize the field resulting in wide-
spread clinical use. Further, a renewed enthusiasm in the field
of meibography is owed to the addition of laser confocal
meibography and OCT meibography. These novel technolo-
gies show promise in their ability to measure unique featuresof the meibomian glands and will likely motivate future stud-
ies in the field of meibography.References
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